These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3195854)

  • 1. [Slow-release theophyllines: serum and saliva levels in asthmatic children].
    Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI
    An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of salivary levels of theophylline in monitoring pediatric asthmatic patients].
    Plaza AM; Farré C; Giner MT; Jiménez CV; Sierra JI
    An Esp Pediatr; 1984 Aug; 21(2):101-6. PubMed ID: 6497187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations.
    Boner AL; Valletta EA; Plebani M; Biancotto R; Bellanti JA
    Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S; Baillie E
    J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring long-term therapy with theophylline preparations in children with asthma].
    Lindemann H; Bauer J; Schwandt HJ
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of salivary with serum levels of retard theophylline under steady-state conditions].
    Virchow C; Schmitz-Schumann M; Mansfeld J
    Pneumologie; 1990 Feb; 44 Suppl 1():281-2. PubMed ID: 2367390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels.
    Eney RD; Goldstein EO
    Pediatrics; 1976 Apr; 57(4):513-7. PubMed ID: 1264547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
    Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
    Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring serum theophylline levels in children. Use of saliva for prediction].
    Dolezalová K; Martínková J; Kopecká J; Kuralová Z; Etlerová E
    Cesk Pediatr; 1989 Oct; 44(10):592-6. PubMed ID: 2620353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma and stimulated-saliva concentrations of theophylline in asthmatic children.
    Krivoy N; Zinman P; Hoffer E; Teitelman U; Rubin A
    Pharmatherapeutica; 1985; 4(5):285-7. PubMed ID: 4070321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are theophylline determinations useful to the clinician during treatment with a sustained-release form of theophylline?].
    Autret E; Lebranchu Y; Blanchard P; Nsabiyumua F; Breteau M; Grenier B; Jonville AP
    Therapie; 1990; 45(1):19-22. PubMed ID: 2343431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.
    Kelly HW; Murphy S
    Pediatrics; 1980 Jul; 66(1):97-102. PubMed ID: 7402798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sustained-release theophylline: study in a child population].
    Díaz Fernández M; Gracía Hidalgo A; Mateo Cañas G; López Elorze F
    An Esp Pediatr; 1986 Jan; 24(1):7-13. PubMed ID: 3963648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW; Murphy S
    Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum theophylline levels after oral administration in a group of asthmatic children].
    Escorihuela R; Llerena P; Royo F; Lillo Lillo M; de la Morena E; Borges Domingo T; López-Linares M
    An Esp Pediatr; 1982 Dec; 17(6):461-5. PubMed ID: 7183217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring children on sustained-release therapy by salivary theophylline levels.
    Kelly HW; Hadley WM; Murphy SA; Skipper BG
    Am J Dis Child; 1981 Feb; 135(2):137-9. PubMed ID: 7468545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.